The ACME Laboratories Ltd. (DSE:ACMELAB)
Bangladesh · Delayed Price · Currency is BDT 73.60
-0.10 (-0.14%)
At close: Jan 22, 2026
The ACME Laboratories Market Cap
The ACME Laboratories has a market cap or net worth of 15.57 billion as of January 23, 2026. Its market cap has decreased by -7.42% in one year.
Market Cap
15.57B
Enterprise Value
36.96B
Revenue
37.48B
Ranking
n/a
PE Ratio
6.20
Stock Price
73.60
Market Cap Chart
Since June 8, 2016, The ACME Laboratories's market cap has decreased from 23.61B to 15.57B, a decrease of -34.05%. That is a compound annual growth rate of -4.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 15.57B | 3.81% |
| Dec 30, 2025 | 15.00B | -5.59% |
| Dec 30, 2024 | 15.89B | -11.65% |
| Dec 28, 2023 | 17.99B | - |
| Dec 29, 2022 | 17.99B | -1.73% |
| Dec 30, 2021 | 18.30B | 15.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 50.95B |
| Renata | 47.45B |
| Unilever Consumer Care | 42.22B |
| Beacon Pharmaceuticals | 24.02B |
| The IBN SINA Pharmaceutical Industry | 10.13B |
| Asiatic Laboratories | 6.56B |
| Orion Pharma | 6.51B |
| Navana Pharmaceuticals | 5.80B |